Following the trade, Jim Cramer's Charitable Trust will own 800 shares of ABT, increasing its weighting to roughly 2.8% from 2.45%.
Organic sales growth for the underlying base business, which excludes Covid-19 testing-related sales, continued its momentum, growing 10.8% year over year, marking the fifth consecutive quarter of double-digit growth.
Following the better-than-expected quarter, Abbott raised the low end of its full-year adjusted EPS and organic sales outlooks.
The best way to look at the company is by analyzing its underlying business because it does not include Covid-related sales.
Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons:
Jim Cramer's, Abbott, ABT, Jim Cramer, Jim
Organizations:
Abbott Laboratories, ABT, Wall, Abbott's, Pharmaceuticals, CNBC